Catalyst Wire Dossier Catalyst Wire Dossier

Everolimus

everolimus · Hikma Pharmaceuticals USA Inc.
Drug timelines are a Plus or Pro feature.

435 regulatory and trial events tracked for Everolimus, covering 2006-10-26 to 2026-08-28. Get the full timeline:

Most recent: Clinical Trial Results: Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer [Phase 1]

See pricing